Double angled-injection process for supercritical precipitation using various organic solvents

The DASAS process addresses the solubility limitations of conventional SAS by allowing dual solvent injection with adjustable angles, achieving controlled particle formation and encapsulation of diverse compounds, enhancing pharmaceutical and nanomedicine applications.

WO2026239028A1PCT designated stage Publication Date: 2026-11-19UNIV DE CADIZ
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/ES2026/070243
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-12
Filing Date
2026-05-06
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Conventional supercritical antisolvent (SAS) processes are limited by the requirement that all compounds to be co-precipitated or encapsulated must be soluble in the same solvent, restricting the versatility and efficiency of particle formation and encapsulation processes.

Method used

The Dual Angular Supercritical Antisolvent (DASAS) process introduces a double-injection configuration with adjustable angles between 0° and 90°, allowing simultaneous introduction of multiple fluid streams with different solvents, and precise control over injection rates, pressure, and temperature to overcome solubility limitations and enhance encapsulation and co-precipitation.

Benefits of technology

DASAS enables the production of micro and nanoparticles with controlled morphology and size distribution, facilitating the encapsulation of compounds insoluble in the same solvent, particularly useful for pharmaceutical and nanomedicine applications, and adaptable to a wide range of compounds and solvents.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure ES2026070243_19112026_PF_FP_ABST
    Figure ES2026070243_19112026_PF_FP_ABST
Patent Text Reader

Abstract

The invention relates to a double angled-injection process for supercritical precipitation using various organic solvents. The process is based on a device containing a double-nozzle system with a variable injection angle, which enables the encapsulation / co-precipitation of compounds with incompatible solubility in organic solvents, overcoming limitations of the supercritical antisolvent (SAS) process, and provides greater control over the size, morphology and distribution of particles. Angle adjustment, injection speed control and the selection of solvents that are miscible in supercritical CO2 provide versatility in the design and production of materials. The invention is especially useful for creating metal-organic compounds and controls the injection angle to adjust encapsulation, influencing the degree of encapsulation and the amount of active ingredient. The invention provides a method and a versatile and efficient device for producing specially made micro / nanoparticles for use in the pharmaceutical industry, nanomedicine and materials science.
Need to check novelty before this filing date? Find Prior Art

Description

[0001]

[0002] DESCRIPTION

[0003] DOUBLE ANGLED INJECTION PROCESS FOR SUPERCRITICAL PRECIPITATION USING DIFFERENT ORGANIC SOLVENTS.

[0004] TECHNICAL SECTOR

[0005] The present invention is a modification of the Supercritical Antisolvent Process (SAS), allowing for double injection, angulation, and the use of non-soluble compounds in the same solvent to co-precipitate and / or encapsulate them using supercritical CO2. This process has been named the Dual Angular Supercritical Antisolvent Process (DASAS).

[0006] In the SAS process, a solution of the active substance is injected through a nozzle into a vessel containing supercritical CO2, producing an atomized spray. The CO2 then diffuses into the solvent droplets, and vice versa, leading to a high degree of supersaturation of the mixture solution. This supersaturation causes the precipitation of the compounds of interest, free of organic solvent. The DASAS process allows for the simultaneous precipitation of two solutions, using the same or different solvents, in the same precipitator. Furthermore, it allows for the regulation of the angle of incidence between the two sprays formed during injection, their injection rate, and the execution time, providing versatility and enabling the exploration of new ways to improve encapsulation and, consequently, release rates.

[0007] BACKGROUND OF THE INVENTION

[0008] Any substance is characterized by its critical point, defined at a specific pressure and temperature. When a substance is above its critical point, it is considered to be in the supercritical region [1]. Within this supercritical region, fluids exhibit behavior intermediate between liquid and gas. They acquire densities more typical of a liquid, while their viscosity and diffusivity are more similar to those of a gas [2,3]. Carbon dioxide is by far the most widely used supercritical fluid. There are several reasons for this. CO2 is a chemically inert, non-toxic, and non-flammable substance, considered a "green" compound. The low temperature at which it reaches its critical point (31.1°C) allows it to treat compounds sensitive to high temperatures. Its supercritical pressure is 73 bar, relatively easy to achieve without consuming excessive energy.Furthermore, its market price is very cheap compared to other compounds [1,4]. In addition, it is a good solvent for non-polar and low molecular weight compounds.Conversely, for compounds with a high molecular weight and most polar compounds, it is not a good solvent [5]. Usually, to increase the solubility of those compounds in which SCCO2 has little solvent power, small amounts of cosolvents are added that increase the solvent capacity of the mixture [6,7]. The versatility of SCCO2 has allowed the proposal and development of different micronization / nanonization technologies over the years, exploiting the supercritical fluid as a solvent, antisolvent, or cosolvent [8]. The combination of liquid-like properties (high density, high solvent power) and gas-like properties (high diffusivity, low viscosity, or almost zero surface tension) of SCCO2 allows the production of particles / crystals of smaller dimensions and with narrower particle size distributions than can be obtained with other more conventional techniques.Thanks to obtaining materials with particle sizes on the order of micrometers or nanometers, it is possible to increase the bioavailability of different active ingredients since their specific surface area is increased.

[0009] Conventional methods for particle size reduction such as “spray drying”, “jet milling”, “freeze drying” or “recrystalization” have disadvantages in achieving high homogeneity in particle size, presence of toxic substances or with traces of organic solvents [9-11]. Various studies have shown that the SAS technique is more effective in obtaining particles of suitable size for pharmaceutical applications than conventional processes, such as lyophilization, spray drying, milling technologies and solvent evaporation [12-14].

[0010] Many active ingredients and most polymers are poorly soluble in supercritical CO2, making its use as an antisolvent for particle formation a widespread practice. The literature uses several different acronyms for particle micronization processes using supercritical CO2 as an antisolvent, including GAS (gas antisolvent), PCA (precipitation by compressed antisolvent), ASES (aerosol solvent extraction system), and SAS (supercritical antisolvent), with the latter being the most commonly used. The principles and mechanisms of these techniques are described in detail by A. Martín et al.

[0015] and E. Reverchon

[0016] , among others.

[0011] The SAS technique generally involves spraying a solution of the solute to be precipitated into a supercritical fluid. This results in rapid volumetric expansion of the solvent due to the extensive diffusion of the supercritical fluid into the solvent droplets. This expansion reduces the solvent's solvation capacity, leading to supersaturation of the liquid phase and the subsequent generation of particles. When this technique is used for encapsulation, both the active ingredient and the polymer must be insoluble in the supercritical fluid, and the organic solvent used must be miscible or partially miscible in supercritical CO2. There is extensive literature on compounds micronized using this technique, particularly in the pharmaceutical and nanomedicine fields. Many of these are covered in the articles by Esfandiari et al.

[0017] and Camparderi et al.[

[0018] , When instead of a pure compound the antisolvent technique is used in extracts with various families of compounds present in the mixture, the technique is called Supercritical Antisolvent Extraction (SAE)

[0019] , In this case the most polar and high molecular weight compounds precipitate, while the rest remain dissolved in CO2.

[0012] In the case of natural product extracts, one can find the precipitation of pure active ingredients such as Lagerstroemia speciosa and Cinnamomum burmanni

[0020] or impure ones such as olive leaf extracts

[0021] , grape extracts

[0022] , and rosemary leaf extracts

[0023] , where the technique used is called SAE. In this case, a liquid extract is pulverized, not a solution of a pure compound. Regarding pure compounds, precipitation has been found for quercetin [24-26], apigenin

[0027] , vitexin

[0028] , mangiferin

[0029] , and Ginkgo biloba

[0030] , atorvastatin

[0031] , naproxen

[0032] , insulin

[0033] , camptothecin

[0034] , resveratrol

[0035] , taxol

[0036] , felodipine

[0037] , and ibuprofen

[0038] , among others. In the case of compounds present in natural extracts, active ingredients such as hespehdin

[0039] , curcumin, and p-carotene co-precipitated with PVP [40,41] have been successfully precipitated.

[0013] Apart from natural active ingredients, it is interesting to see which polymers have also been precipitated with this technique, since they are the most commonly used compounds for encapsulating active ingredients. Yeo et al.

[0042] conducted a comprehensive review of polymers precipitated with FSC, including those using the SAS technique. They highlight that from the beginning until the mid-1990s, the range of polymers studied was very broad, from amorphous polymers (polystyrene)

[0043] , rigid crystalline (aromatic polyamide)

[0044] , semi-crystalline (polyacrylonitrile)

[0045] and biopolymers (L-PLA, DL-PLA, PLGA)

[0031] . The authors conclude that using supercritical fluids as an anti-solvent may be a more promising technique than as a solvent, due to their greater production capacity and the diversity of processes that can be applied [46,47]. In the early 2000s, the efforts of Reverchon et al.

[0048] , Sarkah et al.

[0049] and Elvassore et al. stand out.

[0050] of investigating with biopolymers. During the following years, the study with polymers has continued to increase, for example with poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV)

[0051] , polyvinylpyrrolidone (PVP)

[0052] or a block of three polymers poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) (PLLA-b-PEG-b-PLLA)

[0053] . For polymers derived from cellulose, one of the most widespread in pharmacology, we see hydroxypropyl methylcellulose (HPMC), obtaining spheres or ellipses between 190 and 620 nm depending on the conditions used

[0054] or ethyl cellulose and methyl cellulose that precipitated spherically with sizes between 5 and 30 pm

[0055] .

[0014] If we look at the use of SAS for coprecipitation and encapsulation, the term coprecipitation refers to the precipitation of the active ingredient and the encapsulating agent, forming compounds where the active ingredient is not completely covered by a polymer layer. However, in encapsulation, the active ingredient particles are covered by a layer of encapsulating agent. Most often, mixtures of both types of compounds are generated, and the terms coprecipitation and supercritical encapsulation are commonly used interchangeably in the literature. Most microencapsulation techniques, such as spray-drying, spray cooling, spray chilling, air suspension coating, extrusion, freeze-frying, co-crystallization, interfacial polymerization, and coacervation

[0056] , present several drawbacks, such as the use of organic solvents and high processing temperatures.Supercritical fluids, given their particular properties [57-59], are presented as a viable alternative to traditional techniques.

[0015] In this case, the most widely used technique remains SAS, where encapsulation can be achieved in several ways. One possibility is to dissolve both the active ingredient and the polymer in the same solvent, and then inject this solution into a precipitator with SFC, with the drawback of having to use an organic solvent for both compounds. There are a large number of publications on this subject [60-65], Djerafi

[0066] et al. co-precipitate rifampicin with ethyl cellulose, p-carotene co-precipitated with PVP [67,68] and Yang Jin

[0069] et al. obtain the formation of insulin nanospheres with hydroxypropyl methyl cellulose phthalate (HPMCP) or the encapsulation of quercetin particles with ethyl cellulose, achieving average encapsulation percentages greater than 85%, and particle sizes between 150 and 350 nm

[0070] .

[0016] References

[0017] 1. Brunner, G. Supercritical fluids: Technology and application to food processing.

[0018] J. Food Eng. 2005, 67, 21-33.

[0019] 2. Nalawade, S.P.S.P.; Picchioni, F.; Janssen, L.P.B.M. Supercritical carbon dioxide as a green solvent for processing polymer melts: Processing aspects and applications. 2006, 31, 19-43.

[0020] 3. Baiker, A. Supercritical Fluids in Heterogeneous Catalysis. Chem. Rev. 1999,

[0021] 99, 453-473.

[0022] 4. Peach, J.; Eastoe, J. Supercritical carbon dioxide: A solvent like no other.

[0023] Beilstein J. Org. Chem. 2014, 10, 1878-1895.

[0024] 5. Hyatt, J. A. Liquid and Supercritical Carbon Dioxide as Organic Solvents. J. Org.

[0025] Chem. 1984, 49, 5097-5101.

[0026] 6. Johnston, K.P.; Dobbs, J.M.; Wong, J.M. Nonpolar Co-Solvents for Solubility Enhancement in Supercritical Fluid Carbon Dioxide. J. Chem. Eng. Data 1986, 31, 303-308.

[0027] 7. Frolov, A. I.; Kiselev, M.G. Prediction of cosolvent effect on solvation free energies and solubilities of organic compounds in supercritical carbon dioxide based on fully atomistic molecular simulations. J. Phys. Chem. B 2014, 118, 11769-11780.

[0028] 8. Nunes, A.V.M.; Duarte, C.M.M. Dense CO2 as a Solute, Co-Solute or Co-Solvent in Particle Formation Processes: A review. Materials (Basel). 2011, 4, 2017- 2041.

[0029] 9. Fahim, T.K.; Zaidul, I.S.M.; Abu Bakar, M.R.; Salim, U.M.; Awang, M.B.; Sahena, F.; Jalal, K.C.A.; Sharif, K.M.; Sohrab, M.H. Particle formation and micronization using non-conventional techniques- review. Chem. Eng. Process. ProcessIntensif. 2014, 86, 47-52.

[0030] Sanli, D.; Bozbag, S.E.; Erkey, C. Synthesis of nanostructured materials using supercritical CO2: Part I. Physical transformations. J. Mater. Sci. 2012, 47, 2995-3025.

[0031] Kiran, E. Supercritical fluids and polymers - The year in review - 2014. J. Supercrit. Fluids 2016, 110, 126-153.

[0032] Park, J.; Park, H.J.; Cho, W.; Cha, K.H.; Kang, Y.S.; Hwang, S.J. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process. I nt. J. Pharm. 2010, 396, 239-245.

[0033] Lee, C.W.; Kim, S.J.; Youn, Y.S.; Widjojokusumo, E.; Lee, Y.H.; Kim, J.; Lee, Y.W.; Tjandrawinata, R.R. Preparation of bitter taste masked cetirizine dihydrochloride / p- cyclodextrin inclusion complex by supercritical antisolvent (SAS) process. J. Supercrit. Fluids 2010, 55, 348-357.

[0034] Wu, K.E.; Li, J.; Wang, W.; Winstead, D.A. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent. J. Pharm. Sci. 2009, 98, 2422-2431. Martín, A.; Cocero, M.J. Micronization processes with supercritical fluids: Fundamentals and mechanisms. Adv. Drug Deliv. Rev. 2008, 60.

[0035] Reverchon, E. Supercritical antisolvent precipitation of micro- and nanoparticles. J. Supercrit. Fluids 1999, 15, 1-21.

[0036] Esfandiari, N. Production of micro and nano particles of pharmaceutical by supercritical carbon dioxide. J. Supercrit. Fluids 2015, 100, 129-141.

[0037] Campardelli, R.; Baldino, L; Reverchon, E. Supercritical fluids applications in nanomedicine. J. Supercrit. Fluids 2015, 101, 193-214.

[0038] Mur, R.; Pardo, J. I.; Pino-Otín, M.R.; Urieta, J.S.; Mainar, A.M. Supercritical antisolvent fractionation of antioxidant compounds from salvia officinalis. Int. J. Mol. Sci. 2021, 22.

[0039] Hiendrawan, S.; Veriansyah, B.; Widjojokusumo, E.; Tjandrawinata, R. Simultaneous micronization and purification of bioactive fraction by supercritical antisolvent technology. J. Adv. Pharm. Technol. Res. 2017, 8, 52-58.

[0040] Chinnarasu, C.; Montes, A.; Pereyra, C.; Casas, L.; Fernández-Ponce, M.T.; Mantell, C.; Pattabhi, S.; Martinez de la Ossa, E. Preparation of polyphenol fine particles potent antioxidants by a supercritical antisolvent process using different extracts of Olea europaea leaves. Korean J. Chem. Eng. 2016, 33, 594-602. Natolino, A.; Da Porto, C.; Rodríguez-Rojo, S.; Moreno, T.; Cocero, M.J. Supercritical antisolvent precipitation of polyphenols from grape marc extract. J.Supercrit. Fluids 2016, 118, 54-63.

[0041] Visentin, A.; Rodríguez-Rojo, S.; Navarrete, A.; Maestri, D.; Cocero, M.J. Precipitation and encapsulation of rosemary antioxidants by supercritical antisolvent process. J. Food Eng. 2012, 109, 9-15.

[0042] Alessi, P.; Cortesi, A.; De Zordi, N.; Gamse, T.; Kikic, I.; Moneghini, M.; Solinas, D. Supercritical antisolvent precipitation of quercetin systems: Preliminary experiments. Chem. Biochem. Eng. Q. 2012, 26, 391-398.

[0043] Santos, D.T.; Meireles, M.A.A. Micronization and encapsulation of functional pigments using supercritical carbon dioxide. J. Food Process Eng. 2013, 36, 36-49.

[0044] Montes, A.; Pereyra, C.; De La Ossa, E. J.M. J.M. Screening design of experiment applied to the supercritical antisolvent precipitation of quercetin. J. Supercrit. Fluids 2015, 104, 10-18.

[0045] Zhang, J.; Huang, Y.; Liu, D.; Gao, Y.; Qian, S. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur. J. Pharm. Sci. 2013, 48, 740-747.

[0046] Zu, Y.; Zhang, Q.; Zhao, X.; Wang, D.; Li, W.; Sui, X.; Zhang, Y.; Jiang, S.; Wang, Q.; Gu, C. Preparation and characterization of vitexin powder micronized by a supercritical antisolvent (SAS) process. Powder Technol. 2012, 228, 47-55. Montes, A.; Wehner, L.; Pereyra, C.; Ossa, E.J.M. de la Mangiferin nanoparticles precipitation by supercritical antisolvent process. J. Supercrit. Fluids 2016, 112, 44-50.

[0047] Zhao, C.; Wang, L.; Zu, Y.; Li, C.; Liu, S.; Yang, L; Zhao, X.; Zu, B. Micronization of Ginkgo biloba extract using supercritical antisolvent process. Powder Technol.

[0048] 2011, 209, 73-80.

[0049] Kim, M.S.; Jin, S.J.; Kim, J.S.; Park, H.J.; Song, H.S.; Neubert, R.H.H.; Hwang, S.J. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur. J. Pharm. Biopharm. 2008, 69, 454-465.

[0050] Montes, A.; Bendel, A.; Kürti, R.; Gordillo, M.D.; Pereyra, C.; Martinez De La Ossa, E.J. Processing naproxen with supercritical CO2. J. Supercrit. Fluids 2013, 75, 21-29.

[0051] Jin, H.Y.; Xia, F.; Zhao, Y.P. Preparation of hydroxypropyl methyl cellulose phthalate nanoparticles with mixed solvent using supercritical antisolvent process and its application in co-precipitation of insulin. Adv. Powder Technol.

[0052] 2012, 23, 157-163.Zhao, X.; Zu, Y.; Li, Q.; Wang, M.; Zu, B.; Zhang, X.; Jiang, R.; Zu, C. Preparation and characterization of camptothecin powder micronized by a supercritical antisolvent (SAS) process. J. Supercrit. Fluids 2010, 51, 412-419.

[0053] Ha, E.S.; Park, H.; Lee, S.K.; Sim, W.Y.; Jeong, J.S.; Baek, I.H.; Kim, M.S. Pure Trans-resveratrol nanoparticles prepared by a supercritical antisolvent process using alcohol and dichloromethane mixtures: Effect of particle size on dissolution and bioavailability in rats. Antioxidants 2020, 9, 1-16.

[0054] Zhao, X.; Chen, X.; Zu, Y.; Jiang, R.; Zhao, D. Recrystallization and micronization of taxol using the supercritical antisolvent (SAS) process. Ind. Eng. Chem. Res. 2012, 51, 9591-9597.

[0055] Won, D.H.; Kim, M.S.; Lee, S.; Park, J.S.; Hwang, S.J. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int. J. Pharm. 2005, 301, 199-208.

[0056] Montes, A.; Gordillo, M.D.; Pereyra, C.; De Los Santos, D.M.; Martinez De La Ossa, E.J. Ibuprofen-polymer precipitation using supercritical CO2 at low temperature. J. Supercrit. Fluids 2014, 94, 91-101.

[0057] Saad, S.; Ahmad, I.; Kawish, S.M.; Khan, U.A.; Ahmad, F.J.; Ali, A.; Jain, G.K. Improved cardioprotective effects of hesperidin solid lipid nanoparticles prepared by supercritical antisolvent technology. Colloids Surfaces B Biointerfaces 2020, 187, 110628.

[0058] Prosapio, V.; Reverchon, E.; De Marco, I. Coprecipitation of Polyvinylpyrrolidone / p-Carotene by Supercritical Antisolvent Processing. Ind. Eng. Chem. Res. 2015, 54, 11568-11575.

[0059] Chhouk, K.; Wahyudiono; Kanda, H.; Kawasaki, S.I.; Goto, M. Micronization of curcumin with biodegradable polymer by supercritical anti-solvent using micro swirl mixer. Front. Chem. Sci. Eng. 2018, 12, 184-193.

[0060] Yeo, S.-D.S.-D.; Kiran, E. Formation of polymer particles with supercritical fluids: A review. 2005, 34, 287-308.

[0061] Dixon, D.J.; Johnston, K.P.; Bodmeier, R.A. Polymeric materials formed by precipitation with a compressed fluid antisolvent. AIChE J. 1993, 39, 127-139. Yeo, S.-D.; Debenedetti, P.G.; Radosz, M.; Schmidt, H.-W. Supercritical Antisolvent Process for Substituted Para-Linked Aromatic Polyamides: Phase Equilibrium and Morphology Study. Macromolecules 1993, 26, 6207-6210. Luna-Bárcenas, G.; Kanakia, S.K.; Sanchez, I.C.; Johnston, K.P. Semicrystalline microfibrils and hollowfibres by precipitation with a compressed-fluid antisolvent.Polymer (Guildf). 1995, 36, 3173-3182.

[0062] Bleich, J.; Müller, B.W.; WaBmus, W. Aerosol solvent extraction system - a new microparticle production technique. Inf. J. Pharm. 1993, 97, 111-117.

[0063] Tom, J.W.; Debenedetti, P.G. Formation of Bioerodible Polymeric Microspheres and Microparticles by Rapid Expansion of Supercritical Solutions. Biotechnol. Prog. 1991, 7, 403-411.

[0064] Reverchon, E.; Della Porta, G.; De Rosa, I.; Subra, P.; Letourneur, D. Supercritical antisolvent micronization of some biopolymers. J. Supercrit. Fluids 2000, 18, 239-245.

[0065] Sarkari, M.; Darrat, I.; Knutson, B.L. Generation of microparticles using CO2 and CO2 -philic antisolvents. AIChE J. 2000, 46, 1850-1859.

[0066] Elvassore, N.; Baggio, M.; Pallado, P.; Bertucco, A. Production of different morphologies of biocompatible polymeric materials by supercritical CO2 antisolvent techniques. Biotechnol. Bioeng. 2001 , 73, 449-457.

[0067] Costa, M.S.; Duarte, A.R.C.; Cardoso, M.M.; Duarte, C.M.M. Supercritical antisolvent precipitation of PHBV microparticles. Int. J. Pharm. 2007, 328, 72-77.

[0068] Prosapio, V.; Reverchon, E.; De Marco, I. Coprecipitation of Polyvinylpyrrolidone / p-Carotene by Supercritical Antisolvent Processing. Ind. Eng. Chem. Res. 2015, 54, 11568-11575.

[0069] Zhan, S.; Cui, L; Zhao, Q.; Wang, J.; Chen, S.; Ding, S. Formation of PLLA-PEG-PLLA microparticles by supercritical antisolvent process. Part. Sci. Technol. 2014, 32, 61-69.

[0070] Vorobei, A.M.; Ustinovich, K.B.; Pokrovskiy, O.I.; Parenago, O.O. ; Lunin, V.V. Preparation of hydroxypropylmethylcellulose microparticles using supercritical antisolvent precipitation. Russ. J. Phys. Chem. B 2015, 9, 1103-1108.

[0071] Duarte, A.R.C.; Gordillo, M.D.; Cardoso, M.M.; Simplicio, A.L.; Duarte, C.M.M. Preparation of ethyl cellulose / methyl cellulose blends by supercritical antisolvent precipitation. Int. J. Pharm. 2006, 311, 50-54.

[0072] Desai, K.G.H.; Park, H.J. Recent developments in microencapsulation of food ingredients. Dry. Technol. 2005, 23, 1361-1394.

[0073] Jung, J.; Perrut, M. Particle design using supercritical fluids: Literature and patent survey. J. Supercrit. Fluids 2001, 20, 179-219.

[0074] Cocero, M.J.M.J.; Martín, Á.; Mattea, F.; Varona, S.; Martin, A.; Mattea, F.; Varona, S. Encapsulation and co-precipitation processes with supercritical fluids: Fundamentals and applications. 2009, 47, 546-555.Shariati, A.; Peters, C.J. Recent developments in particle design using supercritical fluids. Curr. Opin. Solid State Mater. Sci. 2003, 7, 371-383.

[0075] Kim, M.-S.; Kim, J.-S.; Park, H.J.; Cho, W.K.; Cha, K.-H.; Hwang, S.-J. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process. Int. J. Nanomedicine 2011, 6, 2997-3009. Kalani, M.; Yunus, R.; Abdullah, N. Optimizing supercritical antisolvent process parameters to minimize the particle size of paracetamol nanoencapsulated in L-polylactide. Int. J. Nanomedicine 2011, 6, 1101-1105.

[0076] Machado, A.P.D.F.; Rueda, M.; Barbero, G.F.; Martín, Á.; Cocero, M.J.; Martínez, J. Co-precipitation of anthocyanins of the extract obtained from blackberry residues by pressurized antisolvent process. J. Supercrit. Fluids 2018, 137, 81-92.

[0077] Oliveira, D.A.; Mezzomo, N.; Gomes, C.; Ferreira, S.R.S. Encapsulation of passion fruit seed oil by means of supercritical antisolvent process. J. Supercrit. Fluids 2017, 129, 96-105.

[0078] Mezzomo, N.; Oliveira, D.A.; Comim, S.R.R.; Ferreira, S.R.S. Encapsulation of extract from winery industry residue using the supercritical anti-solvent technique. Brazilian J. Chem. Eng. 2016, 33, 589-598.

[0079] Wang, W.; Liu, G.; Wu, J.; Jiang, Y. Co-precipitation of 10-hydroxycamptothecin and poly (l-lactic acid) by supercritical CO2anti-solvent process using dichloromethane / ethanol co-solvent. J. Supercrit. Fluids 2013, 74, 137-144. Djerafi, R.; Swanepoel, A.; Crampon, C.; Kalombo, L; Labuschagne, P.; Badens, E.; Masmoudi, Y. Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose. Eur. J. Pharm. Sci. 2017, 102, 161-171.

[0080] Kayrak, D.; Akman, II.; Hortagsu, O. Micronization of Ibuprofen by RESS. J. Supercrit. Fluids 2003, 26, 17-31.

[0081] Yildiz, N.; Tuna,

[0082]

[0083] Dóker, O.; Qalimli, A. Micronization of salicylic acid and taxol (paclitaxel) by rapid expansion of supercritical fluids (RESS). J. Supercrit. Fluids 2007, 41, 440—451.

[0084] Jin, H.Y.; Xia, F.; Zhao, Y.P. Preparation of hydroxypropyl methyl cellulose phthalate nanoparticles with mixed solvent using supercritical antisolvent process and its application in co-precipitation of insulin. Adv. Powder Technol.

[0085] 2012, 23, 157-163.

[0086] Fernández-Ponce, M.T.; Masmoudi, Y.; Djerafi, R.; Casas, L.; Mantell, C.; Ossa, E.M. de la; Badens, E. Particle design applied to quercetin using supercritical anti-solvent techniques. J. Supercrit. Fluids 2014, 105, 119-127.EXPLICACIÓN DE LA INVENCIÓN

[0087] The application of technologies based on the use of supercritical fluids in the field of micro and nanoparticle generation and in the co-precipitation / encapsulation of active ingredient-polymer systems presents great potential, with various techniques developed to obtain these precipitates.

[0088] The SAS technique, with all its variations, generally consists of spraying a solution of the solute to be precipitated into the supercritical fluid through a nozzle. This causes rapid volumetric expansion of the solvent due to the extensive diffusion of the supercritical fluid into the solvent droplets. This expansion reduces the solvent's solvation capacity, leading to supersaturation of the liquid phase and the subsequent generation of particles. When using this technique, both the active ingredient and the polymer must be insoluble in the supercritical fluid. The co-precipitation process can be carried out using a solution of both compounds in a solvent or solvent mixture followed by precipitation, or by suspending previously precipitated drug particles in a polymer solution and then precipitating this suspension.

[0089] The present invention extends the SAS process, allowing co-precipitation by adding a second micrometric nozzle, which allows the injection of two solutions with different solvents and angles the incidence between them between 0 o and 90°. This expands the range of operation for the formation of co-precipitates or encapsulates of mixed compounds, which until now had to be soluble in the same solvent to be created by a SAS process, and adds the advantage of angle to improve and diversify the results of the process.

[0090] A first aspect of the invention consists of an improved precipitation and encapsulation process, called Dual Angular Supercritical Antisolvent (DASAS), which represents a significant evolution of the Supercritical Antisolvent (SAS) method. The conventional SAS process has limitations because it requires that all compounds to be co-precipitated or encapsulated be soluble in the same solvent. To overcome this restriction, the DASAS process introduces an innovative angled double-injection configuration.

[0091] The DASAS process allows the simultaneous introduction of two or more fluid streams, each containing one or more compounds to be precipitated and / or encapsulated, dissolved or dispersed in a solvent, independently, into a vessel containing supercritical CO2. This ability to handle multiple fluid streams with different solvents is fundamental for the co-precipitation and / or encapsulation of compounds that do not share the same solubility in the same organic solvent.

[0092] The angle of incidence between the injected fluid flows is adjustable between 0 oand 90°, allowing modification of the interaction between the compounds in the presence of supercritical CO2. This angular adjustment provides additional control over the morphology, particle size, particle size distribution, and encapsulation or co-precipitation efficiency of the resulting compounds. Furthermore, independent control of the injection rate for each injection flow, along with precise temperature and pressure regulation, further optimizes the process.

[0093] The DASAS process uses supercritical CO2 at a temperature above 31.1°C and a pressure above 73 bar. The choice of organic solvents is based on the solubility of the compounds to be precipitated and / or encapsulated, as well as their complete or partial miscibility in supercritical CO2. This process is particularly useful for generating metal-organic compounds, which often exhibit solubilities in solvents with different compositions. It is also applicable to the encapsulation of active pharmaceutical ingredients with polymers, where the angle of incidence between the nozzles is adjusted to optimize encapsulation.

[0094] A second aspect of the invention is a device for implementing the DASAS process, which is designed to facilitate the co-precipitation and / or encapsulation of compounds by injecting fluids under supercritical conditions. The device comprises several key components that allow for precise and versatile control over the process.

[0095] First, the device includes a precipitation vessel designed to withstand the pressure and temperature conditions of supercritical CO2. This vessel is equipped with two micrometer nozzles arranged so that the angle of incidence of the solutions inside the precipitator can be adjusted. The angle of incidence adjustment system allows the angle between the nozzles to be varied from 0 o at 90°, which facilitates the optimization of the quality of the encapsulation and / or co-precipitation of the compounds.

[0096] In addition, the device features a control system that regulates pressure, temperature, CO2 flow, solution injection rates, and the exposure time of both solutions to supercritical CO2. This control system is essential for maintaining optimal conditions and ensuring reproducible results. A separation system is also included to collect any remaining organic solvents used.

[0097] The control system is configured to optimize the encapsulation of an active ingredient, minimizing its exposure on the surface of the resulting compounds. The ability to adjust the angle of incidence between the nozzles, along with precise control of other process parameters, allows the device to be adapted to a wide variety of applications and compounds.

[0098] The combination of these elements allows the DASAS device to offer an effective and versatile solution for the generation of micro and nanoparticles, as well as for the encapsulation of active ingredient-polymer systems, overcoming the limitations of conventional techniques

[0099] A third aspect of the invention is its potential uses. Some of its most notable uses are detailed below:

[0100] a) Co-precipitation and encapsulation of compounds insoluble in the same solvent: The DASAS process allows the simultaneous introduction of two or more fluid streams, each containing one or more compounds to be precipitated and / or encapsulated, dissolved or dispersed in a solvent, independently, into a vessel containing supercritical CO2. This ability to handle multiple fluid streams with different solvents is fundamental for the co-precipitation and / or encapsulation of compounds that do not share solubility in the same organic solvent. This is particularly useful in the generation of metal-organic compounds, which often exhibit solubilities in solvents with different compositions.

[0101] b) Encapsulation of active ingredients with polymers: The DASAS method is applicable to the encapsulation of active ingredients with polymers, where the angle of incidence between the nozzles is adjusted to optimize encapsulation. Both the active ingredient and the polymer can be dissolved in the same solvent or in different solvents, provided that these solvents are miscible or partially miscible in supercritical CO2.

[0102] c) Control of particle properties: Adjustment of the angle of incidence between the injected fluid flows (between 0 o and 90°) allows modification of the interaction between the compounds and supercritical CO2, providing additional control over the morphology, particle size, particle size distribution and the effectiveness of the encapsulation or co-precipitation of the resulting compounds.

[0103] d) Pharmaceutical and nanomedicine applications: The DASAS method is especially useful in the pharmaceutical and nanomedicine fields, where the production of particles with controlled sizes is required to increase the bioavailability of the active ingredients.

[0104] e) Obtaining polymers with specific characteristics: The DASAS method allows the precipitation of various polymers, including amorphous, crystalline, semi-crystalline, and biopolymers. This is crucial, since polymers are the most widely used compounds for encapsulating active ingredients.

[0105] Among the advantages offered by the invention are the following:

[0106] - Adaptability to different compounds and solvents: The invention offers an effective and versatile solution for the generation of micro- and nanoparticles, as well as for the encapsulation of active ingredient-polymer systems. The ability to adjust the angle of incidence, injection speed, and other process parameters allows the device to be adapted to a wide variety of compounds and solvents, making it a flexible tool adaptable to different needs.

[0107] - Optimization of active ingredient encapsulation: The device's control system is configured to optimize the encapsulation of an active ingredient, minimizing the exposure of the active ingredient on the surface of the resulting particles. This is achieved through precise control of process parameters and adjustment of the angle of incidence. - Generation of metal-organic compounds: The device facilitates the generation of metal-organic compounds thanks to its ability to handle solvents with different compositions, which is essential given that these compounds often exhibit variable solubilities.

[0108] Finally, it is important to mention that the invention is a valuable tool for research and development of new products in various areas, including pharmaceuticals, nanotechnology, and materials science, since its versatility and control capabilities allow for the exploration of new formulations and encapsulation processes with high precision and reproducibility.

[0109] BRIEF DESCRIPTION OF THE DRAWINGS

[0110] Figure 1 - Complete diagram of DASAS equipment

[0111] Figure 2 - Detail of double nozzle and angulation of the DASAS equipment

[0112] PREFERRED EMBODIMENT OF THE INVENTION

[0113] The preferred embodiment of the process that is the subject of the invention is defined below, including its stages and its fundamental characteristics: double / multiple injection, capacity for different solvents, adjustable angulation, and control of key parameters.

[0114] This process comprises the following stages:

[0115] a) Introduce supercritical carbon dioxide into a precipitation vessel. b) Prepare at least two fluid streams, each containing one or more compounds to be precipitated and / or encapsulated, dissolved or dispersed in a solvent, where the solvents of the different streams may be the same or different.

[0116] c) Simultaneously inject at least two fluid flows into the precipitation vessel using at least two micrometric nozzles arranged inside the vessel.

[0117] d) Adjust the angle of incidence between the injection directions of the at least two fluid flows within the precipitation vessel, said angle being adjustable between 0 oand 90°.e) Maintain and control process parameters, including the pressure and temperature of the supercritical carbon dioxide, the injection rates of the fluid flows, and the exposure time of the flows to the supercritical carbon dioxide. f) Allow the precipitation and / or encapsulation of the compounds induced by the supercritical carbon dioxide.

[0118] g) Collect the precipitated and / or encapsulated compounds from the precipitation container.

[0119] Supercritical carbon dioxide is used at a temperature above 31.1°C and a pressure above 73 bar, and the solvents used are miscible or partially miscible in supercritical carbon dioxide. The different organic solvents are selected based on the solubility of the compounds to be precipitated and / or encapsulated and their total or partial miscibility in supercritical CO2.

[0120] The device for carrying out the process, which is also the subject of the invention, comprises:

[0121] a) A precipitation vessel configured to withstand supercritical carbon dioxide pressure and temperature conditions.

[0122] b) At least two micrometric nozzles arranged inside the precipitation vessel. c) A system for adjusting the relative position of the at least two micrometric nozzles, such that the angle of incidence between the fluid injection directions from said nozzles inside the precipitation vessel is adjustable between 0 o and 90°.

[0123] d) A control system configured to regulate the pressure and temperature inside the precipitation vessel, the flow of supercritical carbon dioxide, the fluid injection rates through the nozzles, and the exposure time of the fluids to supercritical carbon dioxide.

[0124] e) A separation system to collect the precipitated and / or encapsulated compounds from the precipitation vessel.

[0125] Based on research and using the conventional SAS technique, a test was conducted to evaluate how different angles of incidence affect the encapsulation of an active compound, amoxicillin, using a polymer, in this case PVP. Fixed values ​​were established for pressure (180 bar), temperature (35°C), CO2 flow rate (20 g / min), and injection rate of each compound separately (5 mL / min). Subsequently, SEM analysis was performed to examine the morphology of the resulting compounds, elemental microanalysis to identify the presence and quantity of amoxicillin in the samples, and XPS tests to determine the amount of compounds on the surface of the encapsulated products and verify the effectiveness of the encapsulation.The fact that amoxicillin has sulfur (S) in its organic formulation and PVP does not, allows us to use this element as a reference for the presence of amoxicillin in the different samples obtained for different angles.

[0126] 1. Relationship between the presence of sulfur on the surface and the total:

[0127] A low sulfur value on the surface relative to the total content is understood to indicate good encapsulation, since the amoxicillin is mostly inside the polymer.

[0128] Conversely, if the percentage of sulfur on the surface is close to or higher than the total percentage, this would suggest that amoxicillin is exposed on the surface, which could compromise encapsulation and affect the controlled release of the drug.

[0129] 2. Table of results in terms of encapsulation effectiveness:

[0130] Test Angle (°) %Total Sulfur %Sulfur Surface Surface / Total Ratio D1 90 2.4 3.4 1.4

[0131] D2 60 1.4 1.7 1.2

[0132] D3 45 0.7 1.9 2.8

[0133] D4 30 1.0 2.9 2.9

[0134] D5 0 0.7 3.5 4.9

[0135]

[0136] 3. Surface / Total Ratio Analysis: The Surface / Total ratio indicates how much amoxicillin (sulfur) is exposed on the surface compared to the total. Lower values ​​indicate better encapsulation.

[0137] D1 (90 o ): Ratio of 1.4. This indicates that there is 43% more sulfur on the surface than the overall average, suggesting that the encapsulation is not perfect, but it is better than at other, smaller angles.

[0138] D2 (60 o ): Ratio of 1.2, which implies better encapsulation than D1, since the percentage on the surface is closer to the total content.

[0139] D3 (45°), D4 (30°), and D5 (0°) show increasing ratios of 2.8, 2.9, and 4.9, respectively. These values ​​indicate that there is a large amount of sulfur on the surface compared to the total, suggesting that encapsulation is not effective at these angles.

[0140] Conclusions on encapsulation:

[0141] 1. More effective encapsulation at larger angles:

[0142] - As the angle of incidence decreases, the proportion of sulfur on the surface increases considerably in relation to the total.

[0143] This indicates that smaller angles are more sensitive to detecting surface exposure of sulfur (amoxicillin), revealing that much of the drug is on the surface and is not well encapsulated.

[0144] Larger angles (such as 90° and 60°) provide lower values ​​in the Surface / Total ratio, suggesting more efficient encapsulation.

[0145] 2. The best result observed:

[0146] Test D2 (60°) shows the best Surface / Total ratio (1.2), indicating that in this case there is less exposure of sulfur on the surface relative to the total content, which points to more effective encapsulation compared to the other angles.

[0147] Test D1 (90°) also shows relatively good encapsulation, although not as efficient as in D2.

[0148] 3. Low angles show worse encapsulation:

[0149] Tests with angles of 45°, 30°, and especially 0 o They indicate poor encapsulation, since there is a much greater exposure of amoxicillin on the surface in relation to the total content.

[0150] It should be noted that in this type of process, perfect encapsulation is not always the goal. Therefore, the validity of the new invention depends not only on the effectiveness of the encapsulation, but also on its versatility in being able to encapsulate and / or co-precipitate two compounds that might be insoluble in the same solvent. Subsequently, thanks to the injection angles, the quality of the encapsulation and / or co-precipitation can be adjusted, either in terms of the percentage of encapsulation or the amount of active ingredient present in the final sample or other relevant final product.

Claims

CLAIMS 1. A double-angle injection process for the precipitation and / or encapsulation of compounds, characterized by employing supercritical carbon dioxide as an antisolvent and using at least two micrometric nozzles for the simultaneous injection of two miscible or partially miscible solutions in supercritical CO2, wherein the angle of incidence between the injection directions of said fluid flows is adjustable between 0 o and 90°.

2. A double-angled injection process for the precipitation and / or encapsulation of compounds, according to claim 1, characterized by comprising the steps of: a) Introduce supercritical carbon dioxide into a precipitation container. b) Prepare at least two fluid streams, each containing one or more compounds to be precipitated and / or encapsulated, dissolved or dispersed in a solvent, where the solvents of the different streams may be the same or different. c) Simultaneously inject the at least two fluid streams into the precipitation vessel using at least two micrometric nozzles arranged inside the vessel. d) Maintain and control process parameters, including the pressure and temperature of supercritical carbon dioxide, the injection rates of the fluid flows, and the exposure time of the flows to supercritical carbon dioxide. e) Allow precipitation and / or encapsulation of compounds induced by supercritical carbon dioxide. f) Collect the precipitated and / or encapsulated compounds from the precipitation container.

3. A double angled injection process for the precipitation and / or encapsulation of compounds, according to claim 2, characterized in that the supercritical CO2 is used at a temperature above 31.1 °C and a pressure above 73 bar.

4. A double angled injection process for the precipitation and / or encapsulation of compounds, according to claim 3, characterized in that the angle of incidence between the fluid flows is 60°.

5. A double angled injection process for the precipitation and / or encapsulation of compounds, according to any of the preceding claims, characterized in that the organic solvents are miscible or partially miscible in supercritical CO2.

6. A double angled injection process, according to the preceding claims, for the co-precipitation and / or encapsulation of compounds that require different organic solvents for their solubilization.

7. A double angled injection process, according to claim 1, for the generation of metal-organic compounds.

8. A double angled injection process, according to claim 1, for the encapsulation of active ingredients with polymers, wherein the active ingredient and the polymer can be dissolved in the same solvent or in different solvents, and wherein the solvent or solvents are miscible or partially miscible in supercritical CO2.

9. A double-angled injection process, according to claim 8, for the encapsulation of active ingredients with polymers, wherein the polymers are selected from the set consisting of: Amorphous polymers. Crystalline polymers. Semi-crystalline polymers. Biopolymers. Cellulose derivatives. Combinations of the same.

10. A device for carrying out a precipitation and / or encapsulation process using supercritical carbon dioxide as an antisolvent, characterized by comprising: a) A precipitation vessel configured to withstand supercritical carbon dioxide pressure and temperature conditions. b) At least two micrometric nozzles arranged inside the precipitation vessel. c) A system for adjusting the relative position of at least two micrometric nozzles, so that the angle of incidence between the directions of fluid injection from said nozzles within the precipitation vessel is adjustable between 0 o and 90°. d) A control system configured to regulate the pressure and temperature inside the precipitation vessel, the flow of supercritical carbon dioxide, the fluid injection rates through the nozzles, and the exposure time of the fluids to supercritical carbon dioxide. e) A separation system to collect the precipitated and / or encapsulated compounds from the precipitation vessel.